Sunshine Biopharma Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Sunshine Biopharma Inc. (SBFM) has a 3-month relative strength percentile of 2 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 23. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 11.1%, relative volume 0.07×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
2 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
SBFM is in a stage 4 downtrend, week 7. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -62.3% / -81.4%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SBFM Jan avg: 20.20% median: -2.84% win: 25% σ: 48.04% n: 4 2022-04-12 → 2026-05-29 | SBFM Feb avg: -31.62% median: -23.25% win: 0% σ: 32.90% n: 4 2022-04-12 → 2026-05-29 | SBFM Mar avg: -9.90% median: -14.96% win: 25% σ: 12.94% n: 4 2022-04-12 → 2026-05-29 | SBFM Apr avg: -34.78% median: -29.32% win: 0% σ: 30.72% n: 5 2022-04-12 → 2026-05-29 | SBFM May avg: -30.96% median: -28.40% win: 20% σ: 34.03% n: 5 2022-04-12 → 2026-05-29 | SBFM Jun avg: -17.13% median: -17.93% win: 25% σ: 13.96% n: 4 2022-04-12 → 2026-05-29 (current) | SBFM Jul avg: -8.10% median: 0.00% win: 25% σ: 18.35% n: 4 2022-04-12 → 2026-05-29 | SBFM Aug avg: -15.32% median: -7.95% win: 25% σ: 22.72% n: 4 2022-04-12 → 2026-05-29 | SBFM Sep avg: -9.93% median: -10.96% win: 50% σ: 20.75% n: 4 2022-04-12 → 2026-05-29 | SBFM Oct avg: 2.92% median: 2.11% win: 50% σ: 14.19% n: 4 2022-04-12 → 2026-05-29 | SBFM Nov avg: -6.90% median: -5.46% win: 25% σ: 8.32% n: 4 2022-04-12 → 2026-05-29 | SBFM Dec avg: -8.85% median: -10.60% win: 25% σ: 10.67% n: 4 2022-04-12 → 2026-05-29 |